Cited 2 times in
PD-L1 expression and overall survival in Asian and western patients with gastric cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김효송 | - |
dc.contributor.author | 라선영 | - |
dc.contributor.author | 정현철 | - |
dc.date.accessioned | 2022-08-23T00:28:51Z | - |
dc.date.available | 2022-08-23T00:28:51Z | - |
dc.date.issued | 2022-07 | - |
dc.identifier.issn | 1479-6694 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/189453 | - |
dc.description.abstract | Aim: Data are limited on PD-L1 expression and its association with overall survival (OS) in gastric cancer (GC) patients receiving routine care in different regions. Materials & methods: In a retrospective study, PD-L1 expression was assayed using the 22C3 pharmDx on GC tumor samples collected between 2003 and 2017 at South Korean and US cancer centers. PD-L1 positivity was defined as combined positive score (CPS) ≥1. The relationship between PD-L1 and OS was analyzed. Results: Of 574 GC tumor samples, 67.4% were CPS ≥1 (68.7% in Korean and 65.7% in US patients). PD-L1 expression was not associated with OS (adjusted hazard ratio: 0.94; 95% CI: 0.75-1.17). Conclusion: PD-L1 prevalence and its association with OS was similar between South Korean and US GC patients. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Future Medicine Ltd. | - |
dc.relation.isPartOf | FUTURE ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | B7-H1 Antigen* / metabolism | - |
dc.subject.MESH | Biomarkers, Tumor / metabolism | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Retrospective Studies | - |
dc.subject.MESH | Stomach Neoplasms* / pathology | - |
dc.title | PD-L1 expression and overall survival in Asian and western patients with gastric cancer | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Sun Young Rha | - |
dc.contributor.googleauthor | Geoffrey Y Ku | - |
dc.contributor.googleauthor | Hyo Song Kim | - |
dc.contributor.googleauthor | Hyun Cheol Chung | - |
dc.contributor.googleauthor | Fatemeh Ghazanfari Amlashi | - |
dc.contributor.googleauthor | Dipen Maheshbhai Maru | - |
dc.contributor.googleauthor | Carly A Fein | - |
dc.contributor.googleauthor | Laura H Tang | - |
dc.contributor.googleauthor | Wei Zhou | - |
dc.contributor.googleauthor | Ting Wu | - |
dc.contributor.googleauthor | Senaka A Peter | - |
dc.contributor.googleauthor | David P Kelsen | - |
dc.contributor.googleauthor | Jaffer A Ajani | - |
dc.identifier.doi | 10.2217/fon-2022-0103 | - |
dc.contributor.localId | A01202 | - |
dc.contributor.localId | A01316 | - |
dc.contributor.localId | A03773 | - |
dc.relation.journalcode | J00914 | - |
dc.identifier.eissn | 1744-8301 | - |
dc.identifier.pmid | 35616013 | - |
dc.identifier.url | https://www.futuremedicine.com/doi/10.2217/fon-2022-0103?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed& | - |
dc.subject.keyword | PD-L1 | - |
dc.subject.keyword | expression | - |
dc.subject.keyword | gastric cancer | - |
dc.subject.keyword | overall survival | - |
dc.subject.keyword | prognosis | - |
dc.contributor.alternativeName | Kim, Hyo Song | - |
dc.contributor.affiliatedAuthor | 김효송 | - |
dc.contributor.affiliatedAuthor | 라선영 | - |
dc.contributor.affiliatedAuthor | 정현철 | - |
dc.citation.volume | 18 | - |
dc.citation.number | 21 | - |
dc.citation.startPage | 2623 | - |
dc.citation.endPage | 2634 | - |
dc.identifier.bibliographicCitation | FUTURE ONCOLOGY, Vol.18(21) : 2623-2634, 2022-07 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.